Garry E. Menzel, Director: Adaptimmune Therapeutics ADAPY Sell · Filed 23/07/10

Trade details

Type: Insider sale
Amount: $43,408.82
Shares · price: 47,702 sh · $0.91 a share
Held after: 75,056 sh
Stock: Adaptimmune Therapeutics ADAPY
Person: Garry E. MenzelDirector
Trade date: 23/07/10
Filed: 23/07/10
Days to filing: 0 days

Sold 38.9% of holdings

Share of holding sold: 38.9%

Adaptimmune Therapeutics trades, last 26 weeks

What else happened in Adaptimmune Therapeutics around then

Filed or reported within 30 days of the trade day · 23/06/10~23/08/09

Garry E. Menzel's recent trades

No other trades yet.